Literature DB >> 12707406

Extracellular matrix metabolism in diabetic nephropathy.

Roger M Mason1, Nadia Abdel Wahab.   

Abstract

Diabetic nephropathy is characterized by excessive deposition of extracellular matrix proteins in the mesangium and basement membrane of the glomerulus and in the renal tubulointerstitium. This review summarizes the main changes in protein composition of the glomerular mesangium and basement membrane and the evidence that, in the mesangium, these are initiated by changes in glucose metabolism and the formation of advanced glycation end products. Both processes generate reactive oxygen species (ROS). The review includes discussion of how ROS may activate intracellular signaling pathways leading to the activation of redox-sensitive transcription factors. This in turn leads to change in the expression of genes encoding extracellular matrix proteins and the protease systems responsible for their turnover.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12707406     DOI: 10.1097/01.asn.0000065640.77499.d7

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  223 in total

1.  CCN-2 is up-regulated by and mediates effects of matrix bound advanced glycated end-products in human renal mesangial cells.

Authors:  Xiaoyu Wang; Susan V McLennan; Stephen M Twigg
Journal:  J Cell Commun Signal       Date:  2011-06-02       Impact factor: 5.782

2.  Evaluation of glycated albumin and microalbuminuria as early risk markers of nephropathy in type 2 diabetes mellitus.

Authors:  Suresh Babu Kondaveeti; Kumaraswamy D; Shishir Mishra; Aravind Kumar R; I Anand Shaker
Journal:  J Clin Diagn Res       Date:  2013-07-01

3.  Store-operated calcium entry suppressed the TGF-β1/Smad3 signaling pathway in glomerular mesangial cells.

Authors:  Sarika Chaudhari; Weizu Li; Yanxia Wang; Hui Jiang; Yuhong Ma; Mark E Davis; Jonathan E Zuckerman; Rong Ma
Journal:  Am J Physiol Renal Physiol       Date:  2017-06-21

4.  Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice.

Authors:  Hui John Zhao; Suwan Wang; Huifang Cheng; Ming-zhi Zhang; Takamune Takahashi; Agnes B Fogo; Matthew D Breyer; Raymond C Harris
Journal:  J Am Soc Nephrol       Date:  2006-09-13       Impact factor: 10.121

Review 5.  Role of growth factors and cytokines in diabetic foot ulcer healing: A detailed review.

Authors:  Mohammad Zubair; Jamal Ahmad
Journal:  Rev Endocr Metab Disord       Date:  2019-06       Impact factor: 6.514

6.  Endothelial or vascular smooth muscle cell-specific expression of human NOX5 exacerbates renal inflammation, fibrosis and albuminuria in the Akita mouse.

Authors:  Jay C Jha; Aozhi Dai; Chet E Holterman; Mark E Cooper; Rhian M Touyz; Chris R Kennedy; Karin A M Jandeleit-Dahm
Journal:  Diabetologia       Date:  2019-06-20       Impact factor: 10.122

Review 7.  The aldo-keto reductase superfamily and its role in drug metabolism and detoxification.

Authors:  Oleg A Barski; Srinivas M Tipparaju; Aruni Bhatnagar
Journal:  Drug Metab Rev       Date:  2008       Impact factor: 4.518

8.  Transforming growth factor-β1 and phosphatases modulate COX-2 protein expression and TAU phosphorylation in cultured immortalized podocytes.

Authors:  Maya S Abdallah; Christopher R J Kennedy; Joseph S Stephan; Pamela Abou Khalil; Mohammad Mroueh; Assaad A Eid; Wissam H Faour
Journal:  Inflamm Res       Date:  2017-10-30       Impact factor: 4.575

9.  Regulation of elongation phase of mRNA translation in diabetic nephropathy: amelioration by rapamycin.

Authors:  Kavithalakshmi Sataranatarajan; Meenalakshmi M Mariappan; Myung Ja Lee; Denis Feliers; Goutam Ghosh Choudhury; Jeffrey L Barnes; Balakuntalam S Kasinath
Journal:  Am J Pathol       Date:  2007-11-08       Impact factor: 4.307

10.  Renoprotective effect of Coccinia indica fruits and leaves in experimentally induced diabetic rats.

Authors:  Mallur Somasundra Abignan Gurukar; Siddaiah Mahadevamma; Nandini Dattatreya Chilkunda
Journal:  J Med Food       Date:  2013-09       Impact factor: 2.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.